Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Shanghai Stock Exchange 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities for the year ending December 31, 2023: USD 49.57 M

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities is USD 49.57 M for the year ending December 31, 2023, a 25.95% change year over year. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities for the year ending December 31, 2022 was USD 39.36 M, a 109.52% change year over year.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities for the year ending December 31, 2021 was USD 18.78 M, a -27.72% change year over year.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities for the year ending December 31, 2020 was USD 25.99 M, a 11.19% change year over year.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Total Non-Current Liabilities for the year ending December 31, 2019 was USD 23.37 M, a 17.47% change year over year.
Key data
Date Total Non-Current Liabilities Shareholders' Equity Other Liabilities Total Liabilities
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 600329.SS

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Description

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.

Similar companies

600267.SS

Zhejiang Hisun Pharmaceutical Co., Ltd.

USD 1.18

0.49%

600285.SS

Henan Lingrui Pharmaceutical Co., Ltd.

USD 2.99

0.60%

600380.SS

Joincare Pharmaceutical Group Industry Co.,Ltd.

USD 1.50

0.37%

StockViz Staff

February 3, 2025

Any question? Send us an email